Cutler Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,900
Closed -$5K 5563
2022
Q3
$5K Buy
+8,900
New +$142K ﹤0.01% 3735
2021
Q1
Sell
-3,700
Closed -$1K 6538
2020
Q4
$1K Sell
3,700
-1,000
-21% -$19.5K ﹤0.01% 4669
2020
Q3
$18K Buy
4,700
+2,700
+135% +$50.2K ﹤0.01% 2549
2020
Q2
$2K Sell
2,000
-1,000
-33% -$13.6K ﹤0.01% 3895
2020
Q1
$27K Hold
3,000
﹤0.01% 2119
2019
Q4
$13K Buy
+3,000
New +$30.2K ﹤0.01% 2503

Other funds holding MYOV

Cutler Group's MYOV Position: Q1 2023 in Review

Cutler Group sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 5,359 shares — an estimated $144K sold.

Cutler Group first reported a position in MYOV in Q1 2020 and held it in 9 quarters. The position peaked at $144K in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Cutler Group reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 5,359 Myovant Sciences Ltd. shares in Q1 2023, an estimated $144K.
  • Cutler Group first reported a position in Myovant Sciences Ltd. in Q1 2020 and held it in 9 quarters.
  • Cutler Group's Myovant Sciences Ltd. position peaked at $144K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.